PT1240310E - Método de inactivação de microrganismos - Google Patents

Método de inactivação de microrganismos Download PDF

Info

Publication number
PT1240310E
PT1240310E PT00993526T PT00993526T PT1240310E PT 1240310 E PT1240310 E PT 1240310E PT 00993526 T PT00993526 T PT 00993526T PT 00993526 T PT00993526 T PT 00993526T PT 1240310 E PT1240310 E PT 1240310E
Authority
PT
Portugal
Prior art keywords
microorganism
inactivant
cross
linking agent
inactivating microorganisms
Prior art date
Application number
PT00993526T
Other languages
English (en)
Inventor
Simon Johannes Barteling
Original Assignee
Inst Animal Science And Health
Agricultural Research Council
Simbar Holding Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Animal Science And Health, Agricultural Research Council, Simbar Holding Nv filed Critical Inst Animal Science And Health
Publication of PT1240310E publication Critical patent/PT1240310E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32161—Methods of inactivation or attenuation
    • C12N2770/32163—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Fertilizers (AREA)
PT00993526T 1999-12-20 2000-12-18 Método de inactivação de microrganismos PT1240310E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA997757 1999-12-20

Publications (1)

Publication Number Publication Date
PT1240310E true PT1240310E (pt) 2008-05-05

Family

ID=25588046

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00993526T PT1240310E (pt) 1999-12-20 2000-12-18 Método de inactivação de microrganismos

Country Status (14)

Country Link
US (1) US6673349B2 (pt)
EP (1) EP1240310B1 (pt)
JP (1) JP2003517834A (pt)
AT (1) ATE384786T1 (pt)
AU (1) AU782907B2 (pt)
BR (1) BR0016563A (pt)
CA (1) CA2394946C (pt)
CY (1) CY1107420T1 (pt)
DE (1) DE60037907T2 (pt)
DK (1) DK1240310T3 (pt)
ES (1) ES2300286T3 (pt)
PT (1) PT1240310E (pt)
TR (1) TR200202104T2 (pt)
WO (1) WO2001046390A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4873632B2 (ja) * 2004-01-21 2012-02-08 メリアル リミテッド 改良された不活化ｆｃｖワクチン
CN102307898A (zh) * 2008-12-19 2012-01-04 株式会社幸福医科 用以蛋白质交联和固定剂固定作为抗原的微生物制造包罗性抗表面抗体的方法
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
CN102406931B (zh) * 2011-11-25 2014-02-05 成都康华生物制品有限公司 大流行流感病毒裂解疫苗
CN105056225B (zh) * 2015-07-30 2018-01-16 成都天邦生物制品有限公司 一种灭活疫苗的制备方法
US10881723B2 (en) 2016-01-15 2021-01-05 Km Biologics Co., Ltd. Vaccine containing immobilized virus particles
CN114540317A (zh) * 2022-03-17 2022-05-27 新疆方牧生物科技有限公司 一种悬浮培养口蹄病毒灭活的工艺方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1924303A1 (de) 1969-05-13 1970-12-17 Bayer Ag AEthylaethylenimin als Inaktivierungsmittel
US5069901A (en) * 1988-02-03 1991-12-03 Jones Elaine V Preparation of a recombinant subunit vaccine against pseudorabies infection
US5242686A (en) 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
GB9110808D0 (en) * 1991-05-17 1991-07-10 Retroscreen Ltd Aids vaccine and method for its production
AU681874B2 (en) * 1993-02-08 1997-09-11 Bayer Corporation Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
TR199801336T2 (xx) * 1996-02-23 1998-10-21 The Procter & Gamble Company Dezenfekte edici bile�imler.

Also Published As

Publication number Publication date
CA2394946C (en) 2010-12-14
CA2394946A1 (en) 2001-06-28
EP1240310A2 (en) 2002-09-18
ATE384786T1 (de) 2008-02-15
BR0016563A (pt) 2002-09-10
DE60037907T2 (de) 2009-07-09
DK1240310T3 (da) 2008-05-26
WO2001046390A2 (en) 2001-06-28
WO2001046390A3 (en) 2001-12-20
AU2979601A (en) 2001-07-03
CY1107420T1 (el) 2012-12-19
US20030035811A1 (en) 2003-02-20
JP2003517834A (ja) 2003-06-03
ES2300286T3 (es) 2008-06-16
DE60037907D1 (de) 2008-03-13
US6673349B2 (en) 2004-01-06
TR200202104T2 (tr) 2002-12-23
AU782907B2 (en) 2005-09-08
EP1240310B1 (en) 2008-01-23

Similar Documents

Publication Publication Date Title
CY1107420T1 (el) Μεθοδος απενεργοποιησεως μικροοργανισμων
AR055422A2 (es) Composicion de antigeno, composicion de vacuna y procedimiento para tratar un cerdo
DK1051506T3 (da) Fremgangsmåde til ekstraktion og isolation af bakterielle kapsel-polysaccharider til anvendelse som vaccine eller sammenkoblet med proteiner som konjugerede vacciner
NZ529881A (en) Capsular polysaccharide solubilisation and combination vaccines
PT865297E (pt) Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
EA199900069A1 (ru) Вакцинная композиция против малярии
PL295727A1 (en) Viral factor associated with an iscrutable swine disease
MXPA01009316A (es) Metodo para exrpesar una molecula antigenica, o una parte de la misma, sobre la superficie de una celula por incorporacion fotoquimica.
AU1199900A (en) Use of purified invaplex from gram negative bacteria as a vaccine
KR930703362A (ko) 병원체로부터 얻은 항원성 폴리오사이드로부터 유도된 올리고사이드
ES2244617T3 (es) Vacunas a base de salmonelas en las cuales los genes ssa han sido inactivados.
DE60226175D1 (de) Mycobakterieller impfstoff
EP1395283A4 (en) HETEROLOGOUS PROTECTION INDUCED BY IMMUNIZATION WITH INVAPLEX VACCINE
DE60124289D1 (de) Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op)
NL300336I2 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
PL355012A1 (en) Vaccine
DE59610629D1 (de) Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine
HUP9702355A2 (hu) Avirulens Mycoplasma synoviae, és az ezt tartalmazó vakcina
DK0757556T3 (da) Borrelia Burgdorferi-bakterin
DE50100698D1 (de) Verfahren zur Herstellung von 1,3,6-Hexantricarbonitril
IL115522A0 (en) Methods for producing enhanced antigenic helicobacter sp and vaccines comprising same
AR027030A1 (es) Metodo para la inactivacion de microorganismos
GB9018061D0 (en) Compositions for vaccines
WO2003054176A3 (en) Preparation of vaccines using photosensitizer and light
UA49450A (uk) Вакцина інактивована рекомбінантна проти інфекційного ринотрахеїту великої рогатої худоби